12 results in Exploration of Targeted Anti-tumor Therapy
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Original Article
Small cell lung cancer: circulating tumor cell lines and expression of mediators of angiogenesis and coagulation
Barbara Rath ... Gerhard Hamilton
Published: April 28, 2023 Explor Target Antitumor Ther. 2023;4:355–365
Open Access
Review
Role of artificial intelligence in oncologic emergencies: a narrative review
Salvatore Claudio Fanni ... Emanuele Neri
Published: April 28, 2023 Explor Target Antitumor Ther. 2023;4:344–354
This article belongs to the special issue Artificial Intelligence for Precision Oncology
Open Access
Review
Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy
Max Kam-Kwan Chan ... Patrick Ming-Kuen Tang
Published: April 28, 2023 Explor Target Antitumor Ther. 2023;4:316–343
This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment
Open Access
Case Report
Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma
Celia Lara-Morga ... Luis Cabezón-Gutiérrez
Published: April 27, 2023 Explor Target Antitumor Ther. 2023;4:307–315
This article belongs to the special issue Biomarkers for Personalized and Precise Cancer Diagnosis and Treatment
Open Access
Original Article
Development and validation of an infrared-artificial intelligence software for breast cancer detection
Enrique Martín-Del-Campo-Mena ... Yessica González-Mejía
Published: April 27, 2023 Explor Target Antitumor Ther. 2023;4:294–306
This article belongs to the special issue Artificial Intelligence for Precision Oncology
Open Access
Systematic Review
Anticancer of genus Syzygium: a systematic review
Mahmoud Dogara Abdulrahman, Harmand A. Hama
Published: April 27, 2023 Explor Target Antitumor Ther. 2023;4:273–293
This article belongs to the special issue Plant Extracts as an Infinite Resource for New Anticancer Agents
Open Access
Case Report
Cystic presentation of primary hepatic neuroendocrine tumour: a case report with a brief review of literature
Mangesh Londhe ... Charusheela Gore
Published: April 26, 2023 Explor Target Antitumor Ther. 2023;4:266–272
This article belongs to the special issue Precision Medicine for Cholangiocarcinoma
Open Access
Review
Gut microbiota, an emergent target to shape the efficiency of cancer therapy
Soumaya Kouidhi ... Amel Ben Ammar El Gaaied
Published: April 26, 2023 Explor Target Antitumor Ther. 2023;4:240–265
This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment
Open Access
Original Article
A potent bioactive fraction against colon cancer from Plectranthus vettiveroides
Faisal M. Athikkavil ... Smitha V. Bava
Published: April 24, 2023 Explor Target Antitumor Ther. 2023;4:227–239
This article belongs to the special issue Plant Extracts as an Infinite Resource for New Anticancer Agents
Open Access
Letter to the Editor
Clinicopathological relevance of stem cell marker growth and differentiation factor 3 in esophageal squamous cell carcinoma
Sara Tahbazzadeh Moghaddam, Mohammad Mahdi Forghanifard
Published: April 24, 2023 Explor Target Antitumor Ther. 2023;4:217–226
Open Access
Review
Ginnalin A and hamamelitannin: the unique gallotannins with promising anti-carcinogenic potential
Rippin ... Anil K. Sharma
Published: April 21, 2023 Explor Target Antitumor Ther. 2023;4:208–216
This article belongs to the special issue Plant Extracts as an Infinite Resource for New Anticancer Agents
Open Access
Review
Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implications
Matthew Moghaddam ... Benjamin Bonavida
Published: April 20, 2023 Explor Target Antitumor Ther. 2023;4:170–207
This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment
Previous